Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walid F Gellad

Showing results (11-20 of 265) with videos related to

Pageof 27
Sort By:
JAMA|October 24, 2019
Adalimumab and the Challenges for BiosimilarsWalid F Gellad, Chester B Good
JAMA Internal Medicine|November 3, 2015
Off-label Drug Use and Adverse Drug Events: Turning up the Heat on Off-label PrescribingChester B Good, Walid F Gellad
Clinics in Geriatric Medicine|April 17, 2012
Medication adherence to multidrug regimensZachary A Marcum, Walid F Gellad
JAMA Internal Medicine|July 2, 2016
Prescription of Brand-Name Medications When Generic Alternatives Are Available-Patently UnfairWalid F Gellad, Chester B Good
The New England Journal of Medicine|May 25, 2017
Accelerated Approval and Expensive Drugs - A Challenging CombinationWalid F Gellad, Aaron S Kesselheim
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 20, 2011
Angiotensin receptor blockers (ARBs)Walid F Gellad, C Bernie Good
Journal of General Internal Medicine|November 17, 2016
Improving Medication Adherence: Keep Your Eyes on the PrizeZachary A Marcum, Walid F Gellad
The New England Journal of Medicine|January 25, 2018
Discounted Drugs for Needy Patients and Hospitals - Understanding the 340B DebateWalid F Gellad, A Everette James
JAMA Internal Medicine|April 5, 2013
Computers and the diagnosis of pneumoniaWalid F Gellad, Donald Yealy, Michael Fine
Archives of Internal Medicine|March 16, 2011
Potential savings from greater use of $4 generic drugsYuting Zhang, Lei Zhou, Walid F Gellad
Pageof 27

Showing results (11-20 of 265) with videos related to

Sort By:
Pageof 27
JAMA|October 24, 2019
Adalimumab and the Challenges for BiosimilarsWalid F Gellad, Chester B Good
JAMA Internal Medicine|November 3, 2015
Off-label Drug Use and Adverse Drug Events: Turning up the Heat on Off-label PrescribingChester B Good, Walid F Gellad
Clinics in Geriatric Medicine|April 17, 2012
Medication adherence to multidrug regimensZachary A Marcum, Walid F Gellad
JAMA Internal Medicine|July 2, 2016
Prescription of Brand-Name Medications When Generic Alternatives Are Available-Patently UnfairWalid F Gellad, Chester B Good
The New England Journal of Medicine|May 25, 2017
Accelerated Approval and Expensive Drugs - A Challenging CombinationWalid F Gellad, Aaron S Kesselheim
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 20, 2011
Angiotensin receptor blockers (ARBs)Walid F Gellad, C Bernie Good
Journal of General Internal Medicine|November 17, 2016
Improving Medication Adherence: Keep Your Eyes on the PrizeZachary A Marcum, Walid F Gellad
The New England Journal of Medicine|January 25, 2018
Discounted Drugs for Needy Patients and Hospitals - Understanding the 340B DebateWalid F Gellad, A Everette James
JAMA Internal Medicine|April 5, 2013
Computers and the diagnosis of pneumoniaWalid F Gellad, Donald Yealy, Michael Fine
Archives of Internal Medicine|March 16, 2011
Potential savings from greater use of $4 generic drugsYuting Zhang, Lei Zhou, Walid F Gellad
Pageof 27